IL303668A - Stable treprostinil prodrugs and their uses for the treatment of diseases - Google Patents
Stable treprostinil prodrugs and their uses for the treatment of diseasesInfo
- Publication number
- IL303668A IL303668A IL303668A IL30366823A IL303668A IL 303668 A IL303668 A IL 303668A IL 303668 A IL303668 A IL 303668A IL 30366823 A IL30366823 A IL 30366823A IL 303668 A IL303668 A IL 303668A
- Authority
- IL
- Israel
- Prior art keywords
- substituted
- prodrug
- treprostinil
- human
- optionally substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063125145P | 2020-12-14 | 2020-12-14 | |
| PCT/US2021/063133 WO2022132655A1 (en) | 2020-12-14 | 2021-12-13 | Methods of treating disease with treprostinil prodrugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL303668A true IL303668A (en) | 2023-08-01 |
Family
ID=79425461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL303668A IL303668A (en) | 2020-12-14 | 2021-12-13 | Stable treprostinil prodrugs and their uses for the treatment of diseases |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11826328B2 (enExample) |
| EP (1) | EP4259121A1 (enExample) |
| JP (1) | JP7826317B2 (enExample) |
| KR (2) | KR20250133451A (enExample) |
| CN (1) | CN117062605A (enExample) |
| AU (1) | AU2021401921A1 (enExample) |
| CA (1) | CA3202061A1 (enExample) |
| IL (1) | IL303668A (enExample) |
| WO (1) | WO2022132655A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250133451A (ko) * | 2020-12-14 | 2025-09-05 | 유나이티드 쎄러퓨틱스 코포레이션 | 트레프로스티닐 프로드러그로 질환을 치료하는 방법 |
| EP4652151A1 (en) | 2023-01-19 | 2025-11-26 | United Therapeutics Corporation | Treprostinil analogs |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2485614A (en) | 1946-08-29 | 1949-10-25 | Chicago Bridge & Iron Co | Stabilizing and guide apparatus for lifter roofs |
| US3037116A (en) | 1957-07-26 | 1962-05-29 | Weber Georges | Apparatus for irradiating liquids |
| US3035516A (en) | 1958-08-18 | 1962-05-22 | Lee Brothers Company | Stencil device |
| US3646509A (en) | 1969-08-08 | 1972-02-29 | Texas Instruments Inc | Method for field stacking seismic data and system using write after read bulk data storage |
| US4306075A (en) | 1980-03-28 | 1981-12-15 | The Upjohn Company | Composition and process |
| US4547016A (en) | 1984-08-13 | 1985-10-15 | Eeco Incorporated | Quick release mounting |
| GB8814438D0 (en) | 1988-06-17 | 1988-07-20 | Wellcome Found | Compounds for use in medicine |
| IT1231076B (it) | 1989-09-28 | 1991-11-12 | Pirelli Cavi Spa | Procedimento per la realizzazione di gruppo di connessione separabile per fibre ottiche riunite a nastro e gruppo di connessione con esso realizzato. |
| GB9011588D0 (en) | 1990-05-24 | 1990-07-11 | Wellcome Found | Prostaglandin analogues for use in medicine |
| US6441245B1 (en) | 1997-10-24 | 2002-08-27 | United Therapeutics Corporation | Process for stereoselective synthesis of prostacyclin derivatives |
| KR100638684B1 (ko) | 1997-11-14 | 2006-10-27 | 유나이티드 세러퓨틱스 코오포레이션 | 말초 혈관 질환의 치료를 위한 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘 에프1의 용도 |
| US6521212B1 (en) | 1999-03-18 | 2003-02-18 | United Therapeutics Corporation | Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation |
| CA2359652A1 (en) | 1999-03-31 | 2000-10-05 | United Therapeutics Corporation | Novel prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of peripheral vascular disease and pulmonaryhypertension |
| US6700025B2 (en) | 2001-01-05 | 2004-03-02 | United Therapeutics Corporation | Process for stereoselective synthesis of prostacyclin derivatives |
| US6803386B2 (en) | 2002-01-16 | 2004-10-12 | United Therapeutics Corporation | Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer |
| US6756117B1 (en) | 2002-12-20 | 2004-06-29 | The United States Of America As Represented By The United States Department Of Energy | Photonic polymer-blend structures and method for making |
| ES2622471T5 (es) | 2003-05-22 | 2020-07-23 | United Therapeutics Corp | Compuestos y procedimientos para la administración de análogos de prostaciclina |
| DE602004028155D1 (de) | 2003-12-16 | 2010-08-26 | United Therapeutics Corp | Verwendung von treprostinil zur behandlung von ischämischen läsionen |
| ATE441418T1 (de) | 2003-12-16 | 2009-09-15 | United Therapeutics Corp | Verwendung von treprostinil zur verbesserung der nierenfunktion |
| US20090124697A1 (en) | 2003-12-16 | 2009-05-14 | United Therapeutics Corporation | Inhalation formulations of treprostinil |
| WO2005099680A2 (en) | 2004-04-12 | 2005-10-27 | United Therapeutics, Inc. | Use of treprostinil to treat neuropathic diabetic foot ulcers |
| US8747897B2 (en) | 2006-04-27 | 2014-06-10 | Supernus Pharmaceuticals, Inc. | Osmotic drug delivery system |
| EP2026816B1 (en) | 2006-05-15 | 2018-10-24 | United Therapeutics Corporation | Treprostinil administration using a metered dose inhaler |
| US20090036465A1 (en) | 2006-10-18 | 2009-02-05 | United Therapeutics Corporation | Combination therapy for pulmonary arterial hypertension |
| JP2010518122A (ja) | 2007-02-09 | 2010-05-27 | ユナイテッド セラピューティクス コーポレーション | 間質性肺疾患および喘息のためのトレプロスチニル処置 |
| CN103181893A (zh) | 2007-09-07 | 2013-07-03 | 联合治疗公司 | 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法 |
| CN101903324B (zh) | 2007-12-17 | 2013-07-03 | 联合治疗公司 | 一种制备Remodulin中的活性成分曲前列素的改良方法 |
| CA2723540C (en) | 2008-05-08 | 2016-01-05 | United Therapeutics Corporation | Treprostinil monohydrate |
| US8349892B2 (en) | 2009-05-07 | 2013-01-08 | United Therapeutics Corporation | Solid formulations of prostacyclin analogs |
| RS53234B (sr) | 2009-08-07 | 2014-08-29 | Scipharm Sàrl | Kompozicija za lečenje cistične fibroze |
| ES2611187T3 (es) | 2010-03-15 | 2017-05-05 | United Therapeutics Corporation | Tratamiento para hipertensión pulmonar |
| JP6046034B2 (ja) | 2010-06-03 | 2016-12-14 | ユナイテッド セラピューティクス コーポレイション | トレプロスチニルの製造 |
| US20120010159A1 (en) * | 2010-07-09 | 2012-01-12 | United Therapeutics Corporation | Combination therapies with cox-2 inhibitors and treprostinil |
| CA2710726C (en) | 2010-07-22 | 2016-02-23 | Alphora Research Inc. | Synthesis of treprostinil and intermediates useful therein |
| CA2710725C (en) | 2010-07-22 | 2017-08-01 | Alphora Research Inc. | Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation |
| CA2726599C (en) | 2010-12-30 | 2017-07-25 | Alphora Research Inc. | Process for treprostinil salt preparation |
| US20130345471A1 (en) | 2011-03-02 | 2013-12-26 | United Therapeutics Corporation | Synthesis of intermediate for treprostinil production |
| US9388154B2 (en) | 2011-09-12 | 2016-07-12 | Lund Biotechnology PBC | Process for preparing synthetic prostacyclins |
| CN103193626B (zh) | 2012-01-10 | 2016-05-11 | 上海天伟生物制药有限公司 | 一种前列腺素类似物的晶型及其制备方法和用途 |
| CN103193627B (zh) | 2012-01-10 | 2016-04-20 | 上海天伟生物制药有限公司 | 一种前列腺素类似物的晶型及其制备方法和用途 |
| US9387214B2 (en) | 2012-01-13 | 2016-07-12 | United Therapeutics Corporation | Method of identifying therapies for pulmonary hypertension |
| LT2674413T (lt) | 2012-06-15 | 2017-09-25 | Scipharm Sąrl | Treprostinilo ir jo darinių gavimo būdas |
| AU2013351934B2 (en) | 2012-11-30 | 2018-03-29 | Insmed Incorporated | Prostacylin compositions and methods for using the same |
| CN104837806A (zh) | 2012-12-07 | 2015-08-12 | 开曼化学股份有限公司 | 前列环素类似物的合成方法 |
| EP3712142B1 (en) * | 2013-01-11 | 2022-07-06 | Corsair Pharma, Inc. | Prodrugs of treprostinil |
| US9505737B2 (en) | 2013-01-11 | 2016-11-29 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
| JP2016517410A (ja) | 2013-03-14 | 2016-06-16 | ユナイテッド セラピューティクス コーポレイション | トレプロスチニルの固体形態 |
| CN109608326A (zh) | 2013-03-15 | 2019-04-12 | 联合治疗公司 | 曲前列环素的盐 |
| US9758465B2 (en) | 2013-04-30 | 2017-09-12 | United Therapeutics Corporation | Controlled release pharmaceutical formulations |
| ES2860975T3 (es) | 2013-10-25 | 2021-10-05 | Insmed Inc | Compuestos de prostaciclina |
| TWI685348B (zh) | 2014-05-08 | 2020-02-21 | 美國禮來大藥廠 | 速效胰島素組合物 |
| CN105723505B (zh) | 2014-05-14 | 2019-03-08 | 富士电机株式会社 | 半导体装置及半导体装置的制造方法 |
| ES2908142T3 (es) | 2014-06-13 | 2022-04-27 | United Therapeutics Corp | Formulaciones de treprostinil |
| US20160045470A1 (en) | 2014-08-12 | 2016-02-18 | Dr. Reddy's Laboratories Limited | Amorphous solid dispersion of treprostinil diethanolamine |
| WO2016038532A1 (en) | 2014-09-09 | 2016-03-17 | Mylan Laboratories Limited | Amorphous treprostinil diethanolamine |
| HU231186B1 (hu) | 2014-10-08 | 2021-06-28 | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. | Új eljárás treprostinil és sói előállítására |
| US9593061B2 (en) | 2014-10-20 | 2017-03-14 | United Therapeutics Corporation | Synthesis of intermediates for producing prostacyclin derivatives |
| AU2015349969B2 (en) * | 2014-11-18 | 2020-02-06 | Insmed Incorporated | Methods of manufacturing treprostinil and treprostinil derivative prodrugs |
| TWI540121B (zh) | 2014-12-01 | 2016-07-01 | 臺灣永光化學工業股份有限公司 | 曲前列環素二乙醇胺之合成方法及新穎中間體 |
| US10837038B2 (en) | 2014-12-23 | 2020-11-17 | National Technology & Engineering Solutions Of Sandia, Llc | Adjusting the pH of a pretreatment solution using carbon dioxide useful for integrating saccharification and fermentation |
| US9394227B1 (en) | 2015-06-17 | 2016-07-19 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| US9643911B2 (en) | 2015-06-17 | 2017-05-09 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| JP7220650B2 (ja) | 2016-09-26 | 2023-02-10 | ユナイテッド セラピューティクス コーポレイション | トレプロスチニルプロドラッグ |
| EP4017588A1 (en) | 2019-08-23 | 2022-06-29 | United Therapeutics Corporation | Treprostinil prodrugs |
| KR20250133451A (ko) * | 2020-12-14 | 2025-09-05 | 유나이티드 쎄러퓨틱스 코포레이션 | 트레프로스티닐 프로드러그로 질환을 치료하는 방법 |
-
2021
- 2021-12-13 KR KR1020257027604A patent/KR20250133451A/ko active Pending
- 2021-12-13 CN CN202180093739.XA patent/CN117062605A/zh active Pending
- 2021-12-13 KR KR1020237023390A patent/KR102849520B1/ko active Active
- 2021-12-13 AU AU2021401921A patent/AU2021401921A1/en active Pending
- 2021-12-13 CA CA3202061A patent/CA3202061A1/en active Pending
- 2021-12-13 JP JP2023535715A patent/JP7826317B2/ja active Active
- 2021-12-13 EP EP21841084.3A patent/EP4259121A1/en active Pending
- 2021-12-13 US US17/549,573 patent/US11826328B2/en active Active
- 2021-12-13 IL IL303668A patent/IL303668A/en unknown
- 2021-12-13 WO PCT/US2021/063133 patent/WO2022132655A1/en not_active Ceased
-
2023
- 2023-11-27 US US18/519,801 patent/US12491170B2/en active Active
-
2025
- 2025-11-14 US US19/389,523 patent/US20260069557A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240130989A1 (en) | 2024-04-25 |
| US12491170B2 (en) | 2025-12-09 |
| CA3202061A1 (en) | 2022-06-23 |
| US11826328B2 (en) | 2023-11-28 |
| JP2023553989A (ja) | 2023-12-26 |
| US20260069557A1 (en) | 2026-03-12 |
| AU2021401921A1 (en) | 2023-07-06 |
| EP4259121A1 (en) | 2023-10-18 |
| KR20250133451A (ko) | 2025-09-05 |
| US20220323387A1 (en) | 2022-10-13 |
| KR102849520B1 (ko) | 2025-08-25 |
| KR20230134480A (ko) | 2023-09-21 |
| CN117062605A (zh) | 2023-11-14 |
| WO2022132655A1 (en) | 2022-06-23 |
| JP7826317B2 (ja) | 2026-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260069557A1 (en) | Stable treprostinil prodrugs | |
| EP4017588A1 (en) | Treprostinil prodrugs | |
| RU2104999C1 (ru) | Двойные ингибиторы no-синтазы и циклооксигеназы, способ их получения, фармацевтическая композиция на их основе | |
| IT8149031A1 (it) | Amidi organiche derivate da lipidi azotati utilizzabili come farmaci | |
| WO2010099698A1 (zh) | 四氢咪唑并[1,5-a]吡嗪衍生物的盐，其制备方法及其在医药上的应用 | |
| US20090170945A1 (en) | Pregabalin salts | |
| US6429229B1 (en) | Keto acid salts and amine derivatives, and their use for preparing medicines | |
| CS214700B2 (en) | Method of making the 9-aminoalcylfluorenes | |
| JPH0335319B2 (enExample) | ||
| US20090215894A1 (en) | Inhibition of phosphatase activity of soluble epoxide hydrolase amino terminus and uses thereof | |
| EP0395529B1 (fr) | Nouveau dérivé d'hydroxyphénéthylamine et ses sels, procédé de préparation, application à titre de médicaments et utilisation comme outil pharmacologique spécifique | |
| CN118891248A (zh) | 苯乙胺及其制备方法 | |
| AU2024289343A1 (en) | Treprostinil derivative, and preparation method therefor and use thereof | |
| EP4185281A1 (fr) | Composés pour le traitement de l'hémophilie | |
| HU198446B (en) | Process for production of new amids of buten acid and medical compositions containing such active substances | |
| US20060111346A1 (en) | Methods of modulating high-density lipoprotein cholesterol levels and pharmaceutical formulations for the same | |
| CH660480A5 (it) | Derivati dell'acido d-2-(6-metossi-2-naftil) propionico ad attivita terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
| IT8224514A1 (it) | Nuovi derivati dell'acido 2-acetossibenzoico | |
| CS214777B2 (cs) | Způsob výroby derivátů kyseliny fenyloctové | |
| SK280148B6 (sk) | Acetylsalicyloyl-l-karnitín a spôsob jeho výroby |